| Potential risk factor of interleukin-10 gene polymorphism in acute myelogenous leukemia | Bilkay BAŞTÜRK,Elif EVKE,Sema KARAKUŞ,Ahmet TUNALI | 57–62 |
| Primary extranodal lymphoma: The comparison of clinical characteristics with nodal lymphoma | DOĞAN UNCU,Nuriye ÖZDEMİR,Şebnem KARAKAN,Çakmak Berna ÖKSÜZOĞLU,Nurullah ZENGİN | 63–67 |
| Gemcitabine treatment in patients with anthracycline- and taxane- pretreated metastatic breast cancer | Bülent KARABULUT, Ulus A. ŞANLI, Rüçhan USLU, Veliddin C. SEZGİN, Erdem GÖKER | 68–72 |
| Use of alternative medicine in patients with lung cancer | Cengiz KURTMAN, Cem ÖNAL, Serap AKYÜREK | 73–77 |
| Fatigue syndrome in patients with lymphoma (Hodgkin and Non-Hodgkin) and influencing factors | Arife AZAK, Sezgi ÇINAR | 78–85 |
| Orbital involvement in the small cell carcinoma of the maxillary sinus: A case report | H. Şenol COŞKUN,Mahmut AKBAŞ,Mehmet ŞAHİN,E. Güçhan ALANOĞLU | 86–89 |
| Synchronous renal cell carcinoma with medullary carcinoma of the breast | Alper SEVİNÇ, Celalettin CAMCI, Mehmet E. KALENDER, Ediz TUTAR | 90–93 |
| Rhabdomyosarcoma of the common bile duct: Case report | Deniz TUĞCU,Ferhan AKICI,Arzu AKÇAY,Zafer SALCIOĞLU,Gönül AYDOĞAN,Hülya ŞEN,Serdar YEŞİNEL,ZERRİN ÖNAL,ENVER MAHİR GÜLCAN,Gülay TİRELİ,Murat ÖNAL,Güngör TEKOĞUL,Rana RAMAZANOĞLU,Sergülen DERVİŞOĞLU | 94–99 |
| Multiple atrial thrombus in a splenectomized patient with thalassemia major | Dede ŞİT, Veysel KIDIR, Ozan BALAKAN, Ali SÜNER, Orhan AYYILDIZ | 100–103 |
| Reports from forty-first American society of clinical oncology (ASCO)-2005 meeting: Trastuzumab use in the adjuvant treatment of breast cancer | Kadri ALTUNDAĞ, Banu ARUN | 104–109 |
| Cutaneous paraneoplastic syndromes | BAŞAK YALÇIN | 110–114 |